SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-24-040606
Filing Date
2024-03-28
Accepted
2024-03-28 17:06:05
Documents
5
Effectiveness Date
2024-03-28

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm249930d2_s8.htm S-8 56098
2 EXHIBIT 5.1 tm249930d2_ex5-1.htm EX-5.1 8196
3 EXHIBIT 23.1 tm249930d2_ex23-1.htm EX-23.1 1952
4 EX-FILING FEES tm249930d2_ex-filingfees.htm EX-FILING FEES 19055
5 GRAPHIC tm249930d2_ex5-1img001.jpg GRAPHIC 4796
  Complete submission text file 0001104659-24-040606.txt   93262
Mailing Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830
Business Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: S-8 | Act: 33 | File No.: 333-278343 | Film No.: 24800216
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)